+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Early Cardiogenic Shock (CS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Early Cardiogenic Shock (CS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Pulmonary Hypertension - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Hypertension - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Giant-Cell Arteritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Giant-Cell Arteritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Recurrent Pericarditis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Recurrent Pericarditis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Arteriovenous Malformations - Epidemiology Forecast - 2032 - Product Thumbnail Image

Arteriovenous Malformations - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cardiac Insufficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cardiac Insufficiency - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
ANCA Vasculitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

ANCA Vasculitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Aortic Stenosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Aortic Stenosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Bleeding Control - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bleeding Control - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Intracranial Arterial Diseases - Epidemiology Forecast to 2032 - Product Thumbnail Image

Intracranial Arterial Diseases - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mitral Valve Insufficiency - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mitral Valve Insufficiency - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Barth Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

Barth Syndrome - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
From
Hypovolemic shock - Pipeline Insight, 2024 - Product Thumbnail Image

Hypovolemic shock - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Giant-Cell Arteritis - Pipeline Insight, 2024 - Product Thumbnail Image

Giant-Cell Arteritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Ventricular Tachycardia (V-tach or VT) - Pipeline Insight, 2024 - Product Thumbnail Image

Ventricular Tachycardia (V-tach or VT) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Critical Limb Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Critical Limb Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more